http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104940399-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-804 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate | 2015-07-07^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-05-29^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-05-29^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104940399-B |
| titleOfInvention | A kind of drug for treating skin pigment depigmentation and leucoderma |
| abstract | The invention discloses a kind of drug for treating skin pigment depigmentation and leucoderma, the component of following weight is included in the drug：Psoralea corylifolia 25~60, safflower 8~30, Radix Salviae Miltiorrhizae 8~20, the root of Dahurain angelica 15~40, black rice shell 8~25, Siberian cocklebur grass 5~20, the fleece-flower root 8~20, Radix Rehmanniae 4~15, Radix Codonopsis 5~15, Radix Paeoniae Alba 5~10, drop smell good 4~15, Semen sesami nigrum 5~20, Asian puccoon 5~20, Radix Angelicae Sinensis 6~20, windproof 5~15.Drug of the present invention can promote skin blood to cycle, promote the generation of local skin melanin, accelerate secretion melanin, so as to cure skin pigment depigmentation and leucoderma, prevent skin pigment depigmentation and leucoderma from recurring, the healing cycle is short, has no toxic side effect, and different constitution patients can be directed to and adjust drug component, improve therapeutic effect. |
| priorityDate | 2015-07-07^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 176 of 176.